PET/CT imaging in different types of lung cancer: An overview

被引：121

作者：

Ambrosini, Valentina ^{[2
]}

Nicolini, Silvia ^{[2
]}

Caroli, Paola ^{[2
]}

Nanni, Cristina ^{[2
]}

Massaro, Arianna

Marzola, Maria Cristina

Rubello, Domenico ^{[1
]}

Fanti, Stefano ^{[2
]}

机构：

[1] Santa Maria della Misericordia Hosp, Dept Radiol, PET CT Ctr, I-45100 Rovigo, Italy

[2] St Orsola Malpighi Hosp, Dept Nucl Med, Bologna, Italy

来源：

EUROPEAN JOURNAL OF RADIOLOGY | 2012年 / 81卷 / 05期

关键词：

Lung cancer; Various types; PET/CT; 18F-FDG; 18F-DOPA; 68Ga-DOTA-peptides; Indications; Drawbacks; POSITRON-EMISSION-TOMOGRAPHY; SOLITARY PULMONARY NODULES; STANDARDIZED UPTAKE VALUE; GUIDELINES 2ND EDITION; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; FORTHCOMING 7TH EDITION; FDG-PET; NEUROENDOCRINE TUMORS; F-18-FDG PET; BRONCHIOLOALVEOLAR CARCINOMA;

D O I：

10.1016/j.ejrad.2011.03.020

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Lung cancer (LC) still represents one of the most common tumours in both women and men. PET/CT is a whole-body non-invasive imaging procedure that has been increasingly used for the assessment of LC patients. In particular, PET/CT added value to CT is mainly related to a more accurate staging of nodal and metastatic sites and to the evaluation of the response to therapy. Although the most common PET tracer for LC evaluation is 18F-FDG, new tracers have been proposed for the evaluation of lung neuroendocrine tumours (68Ga-DOTA-peptides, 18F-DOPA) and for the assessment of central nervous system metastasis (11C-methionine). This review focuses on the main clinical applications and accuracy of PET/CT for the detection of non-small cells lung cancer (NSCLC), broncho-alveolar carcinoma (BAC), small cells lung cancer (SCLC), lung neuroendocrine tumours (NET) and solitary pulmonary nodules (SPN). (C) 2011 Elsevier Ireland Ltd. All rights reserved.

引用

页码：988 / 1001

页数：14

共 50 条

[21] Optimal Imaging Protocols for Lung Cancer Staging CT, PET, MR Imaging, and the Role of Imaging
Paul, Narinder S.
Ley, Sebastian
Metser, Ur
RADIOLOGIC CLINICS OF NORTH AMERICA, 2012, 50 (05) : 935 - +
[22] IMAGING PET-CT imaging in non-small-cell lung cancer
Levine, Mark
Julian, Jim
NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (11) : 619 - 620
[23] Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT Comparison With 18F-FDG PET/CT in 22 Different Cancer Types
Cermik, Tevfik Fikret
Ergul, Nurhan
Yilmaz, Burcak
Mercanoglu, Guldem
CLINICAL NUCLEAR MEDICINE, 2022, 47 (04) : E333 - E339
[24] Staging of lung cancer CT and PET
Theresa C McLoud
Cancer Imaging, 14 (Suppl 1)
[25] Lobar Lung Function Quantification by PET Galligas and CT Ventilation Imaging in Lung Cancer Patients
Eslick, E.
Bailey, D.
Bailey, E.
Kipritidis, J.
Keall, P.
MEDICAL PHYSICS, 2014, 41 (06) : 175 - 175
[26] The usefulness of PET/CT in lung cancer
Pinilla, I.
Gomez Leon, N.
RADIOLOGIA, 2009, 51 (03): : 248 - 260
[27] Characteristics of Primary Lung Cancer on PET/CT Imaging in the South African Population
Evbuomwan, O.
Ayeni, O.
Purbhoo, K.
Vangu, M.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2317 - S2317
[28] Local respiratory motion correction for PET/CT imaging: Application to lung cancer
Lamare, F.
Fayad, H.
Fernandez, P.
Visvikis, D.
MEDICAL PHYSICS, 2015, 42 (10) : 5903 - 5912
[29] PET/CT imaging in response evaluation of patients with small cell lung cancer
Fischer, Barbara M.
Mortensen, Jann
Langer, Seppo W.
Loft, Annika
Berthelsen, Anne K.
Daugaard, Gedske
Lassen, Ulrik
Hansen, Heine H.
LUNG CANCER, 2006, 54 (01) : 41 - 49
[30] Imaging features of 18F-FDG PET/CT in different types of systemic vasculitis
Zhuo Chen
Yunyun Zhao
Qian Wang
Yuan Li
Hebei Li
Yunshan Zhou
Clinical Rheumatology, 2022, 41 : 1499 - 1509

← 1 2 3 4 5 →